Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (441-450 of 643) with videos related to

Pageof 65
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
JCO Precision Oncology|October 31, 2017
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine StudyApostolia-Maria Tsimberidou, David S Hong, Yang Ye, et al.
Investigational New Drugs|April 28, 2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib studyKyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
The Oncologist|March 30, 2021
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical TrialsRyan W Huey, Goldy C George, Penny Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2020
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid TumorsAlexej Ballhausen, Jennifer J Wheler, Daniel D Karp, et al.
Cancer Medicine|November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceZhijie Wang, Naiyi Shi, Aung Naing, et al.
Scientific Reports|October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved TherapiesVivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Cancer|September 21, 2004
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancerJennifer F Tseng, Steven J Kronowitz, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Pageof 65

Showing results (441-450 of 643) with videos related to

Sort By:
Pageof 65
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
JCO Precision Oncology|October 31, 2017
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine StudyApostolia-Maria Tsimberidou, David S Hong, Yang Ye, et al.
Investigational New Drugs|April 28, 2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib studyKyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
The Oncologist|March 30, 2021
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical TrialsRyan W Huey, Goldy C George, Penny Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2020
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid TumorsAlexej Ballhausen, Jennifer J Wheler, Daniel D Karp, et al.
Cancer Medicine|November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceZhijie Wang, Naiyi Shi, Aung Naing, et al.
Scientific Reports|October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved TherapiesVivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Cancer|September 21, 2004
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancerJennifer F Tseng, Steven J Kronowitz, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Pageof 65